NCT01311128

Brief Summary

This protocol will test a new non-invasive device, the T-line, in continuously determining heart rate and blood pressure in operative and critically ill patients. The accuracy of the device will be compared to the standard radial artery catheter, as well as to the non-invasive blood pressure cuff. The T-line will also be compared to the right heart catheter determining cardiac output in at least 20 patients. Hypothesis: the T-line device will determine blood pressure and heart rate as accurately as a standard radial arterial catheter and a blood pressure cuff in perioperative patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
31

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Feb 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 16, 2011

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

March 8, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 9, 2011

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 29, 2012

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2014

Completed
Last Updated

August 28, 2019

Status Verified

August 1, 2019

Enrollment Period

1.4 years

First QC Date

March 8, 2011

Last Update Submit

August 23, 2019

Conditions

Keywords

Blood pressureHeart rateCardiac outputCritical carePerioperative care

Outcome Measures

Primary Outcomes (1)

  • Agreement between radial catheter, blood pressure cuff, and T-line in determining heart rate and blood pressure

    Assessed 24 times over four hours

Secondary Outcomes (1)

  • Agreement between the T-line and right heart catheter in determining cardiac output

    Assessed every 30 minutes over four hours

Study Arms (1)

Heart rate and blood pressure determination

All subjects have the same conditions (T-line, blood pressure cuff, and radial artery catheter), in order to compare them within-subjects.

Device: T-line hemodynamic monitoring device (placement and use)

Interventions

The T-line device will be placed over the contralateral (from the radial artery catheter) radial artery at the distal wrist. To attach the device, a single-use sterile sensor is placed over the radial artery and the device then gently clamped around the wrist to incorporate the sensor. After a ten-minute stabilization period, data will be recorded every ten minutes during the first two hours of surgery, or until the patient is placed on cardiopulmonary bypass. The T-line device will then be removed. This procedure will be repeated, for a second two-hour period, in the ICU postoperatively.

Also known as: T-line, Tensymeter, Tensys Medical, Inc., Hemodynamic monitoring
Heart rate and blood pressure determination

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age at least 18 years old
  • Operative patients expected to require intensive care recovery at OHSU
  • Planned or existing intra- and postoperative radial artery catheterization as part of routine care
  • Palpable contralateral (to catheter) radial artery pulse
  • Planned intraoperative right heart catheter placement as part of routine clinical care, in at least 20 subjects of total

You may not qualify if:

  • No palpable radial artery pulse
  • Anatomical abnormalities (skin grafts, cysts, cellulitis) or injuries (scarring, cuts, burns, bruising) at the sensor site
  • An intravenous line placed at the sensor application site or within the medial/lateral travel range of the sensor
  • An AV shunt in the T-line arm
  • Known sensitivity to pressure stimuli (dermatographism)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Oregon Health & Science University

Portland, Oregon, 97239, United States

Location

MeSH Terms

Conditions

Critical Illness

Interventions

Mutagenesis, InsertionalHemodynamic Monitoring

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Protein EngineeringGenetic EngineeringGenetic TechniquesInvestigative TechniquesMutationGenetic VariationGenetic PhenomenaMutagenesisDiagnostic Techniques, CardiovascularDiagnostic Techniques and ProceduresDiagnosisMonitoring, Physiologic

Study Officials

  • Charles Phillips, MD

    503-494-2465

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 8, 2011

First Posted

March 9, 2011

Study Start

February 16, 2011

Primary Completion

June 29, 2012

Study Completion

December 30, 2014

Last Updated

August 28, 2019

Record last verified: 2019-08

Locations